Northern Trust Corp Bio Xcel Therapeutics, Inc. Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

A detailed history of Northern Trust Corp transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 194,953 shares of BTAI stock, worth $142,315. This represents 0.0% of its overall portfolio holdings.

Number of Shares

194,953

Previous 211,602 7.87%

Holding current value

$142,315

Previous $596,000 58.22%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.14 - $2.97 $18,979 - $49,447	-16,649 Reduced 7.87%	194,953 $249,000
Q1 2024 May 14, 2024	SELL	$1.95 - $4.04 $26,884 - $55,699	-13,787 Reduced 6.12%	211,602 $596,000
Q4 2023 Feb 13, 2024	SELL	$2.32 - $5.51 $619 - $1,471	-267 Reduced 0.12%	225,389 $664,000
Q3 2023 Nov 13, 2023	SELL	$2.49 - $11.85 $45,940 - $218,632	-18,450 Reduced 7.56%	225,656 $570,000
Q2 2023 Aug 11, 2023	BUY	$6.39 - $28.58 $207,297 - $927,163	32,441 Added 15.33%	244,106 $1.63 Million
Q1 2023 May 15, 2023	SELL	$17.7 - $33.24 $71,030 - $133,392	-4,013 Reduced 1.86%	211,665 $3.95 Million
Q4 2022 Feb 13, 2023	BUY	$10.25 - $22.43 $80,001 - $175,066	7,805 Added 3.75%	215,678 $4.63 Million
Q3 2022 Nov 14, 2022	BUY	$11.19 - $17.89 $21,149 - $33,812	1,890 Added 0.92%	207,873 $2.46 Million
Q2 2022 Aug 12, 2022	BUY	$9.03 - $21.55 $102,752 - $245,217	11,379 Added 5.85%	205,983 $2.72 Million
Q1 2022 May 13, 2022	BUY	$15.0 - $22.83 $19,455 - $29,610	1,297 Added 0.67%	194,604 $4.07 Million
Q4 2021 Feb 08, 2022	BUY	$20.12 - $35.09 $64,565 - $112,603	3,209 Added 1.69%	193,307 $3.93 Million
Q3 2021 Nov 15, 2021	BUY	$23.84 - $32.03 $222,379 - $298,775	9,328 Added 5.16%	190,098 $5.77 Million
Q2 2021 Aug 13, 2021	BUY	$29.06 - $38.83 $429,332 - $573,674	14,774 Added 8.9%	180,770 $5.25 Million
Q1 2021 May 12, 2021	SELL	$39.04 - $64.6 $838,657 - $1.39 Million	-21,482 Reduced 11.46%	165,996 $7.17 Million
Q4 2020 Feb 11, 2021	SELL	$42.46 - $56.58 $101,606 - $135,395	-2,393 Reduced 1.26%	187,478 $8.66 Million
Q3 2020 Nov 16, 2020	BUY	$37.44 - $64.63 $614,278 - $1.06 Million	16,407 Added 9.46%	189,871 $8.23 Million
Q2 2020 Aug 14, 2020	BUY	$17.62 - $58.71 $784,794 - $2.61 Million	44,540 Added 34.55%	173,464 $9.2 Million
Q1 2020 May 14, 2020	BUY	$12.26 - $41.14 $130,225 - $436,989	10,622 Added 8.98%	128,924 $2.88 Million
Q4 2019 Feb 14, 2020	BUY	$4.05 - $14.61 $27,252 - $98,310	6,729 Added 6.03%	118,302 $1.73 Million
Q3 2019 Nov 13, 2019	BUY	$7.04 - $11.77 $476,967 - $797,429	67,751 Added 154.6%	111,573 $786,000
Q2 2019 Aug 13, 2019	BUY	$8.99 - $11.79 $280,649 - $368,060	31,218 Added 247.68%	43,822 $481,000
Q1 2019 May 13, 2019	BUY	$3.49 - $10.47 $43,987 - $131,963	12,604 New	12,604 $125,000

Others Institutions Holding BTAI

# of Institutions

Shares Held

7.2M

Call Options Held

101K

Put Options Held

205K

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $20.5M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Bio Xcel Therapeutics, Inc. Transaction History